New test takes guesswork out of diagnosing early-stage Alzheimer’s disease
A new test developed by Japanese scientists may revolutionize how and when physicians diagnose Alzheimer’s disease. According to new research, the new test measures proteins in the spinal fluid known to be one of the main causes of brain degeneration and memory impairment in Alzheimer’s patients: high molecular weight A-Beta oligomers.
Related posts:
- Poor Money Management May Be Early Indicator Of Alzheimer’s Disease, Say UAB Researchers Inability to handle financial transactions or manage money may be...
- Memory may decline rapidly even in stage before Alzheimer’s disease Memory and thinking skills may decline rapidly for people who...
- Fruit flies and test tubes open new window on Alzheimer’s disease Scientists have discovered a molecule that can prevent a toxic...
- New Alzheimer’s test offers better opportunities for early detection Early detection is key to more effective treatment for Alzheimer's...
- Brain plaques in healthy individuals linked to increased Alzheimer’s risk Scientists have long assumed that amyloid brain plaques found in...
Related posts brought to you by Yet Another Related Posts Plugin.
Read the original post at ScienceDaily: Psychology News ...
Post it to Twitter